iiinova — where your digital self keeps evolving

Adu Subramanian @plainyogurt21.bsky.social · 25/05/2025

Which stock is this? Let's see if people remember pre covid. Hint in next comment

Adu Subramanian @plainyogurt21.bsky.social · 18/03/2025

American College of Cardiology (ACC) 2025 is < 2 weeks away. I've indexed all 4600+ abstracts with tagged by trial ID, drug, conditions, type of study, and summaries, email me at adu.subramanian@subradata.com for the excel grouped by session.

100

Adu Subramanian @plainyogurt21.bsky.social · 26/02/2025

AI for Research: A Practical Guide for Analysts open.substack.com/pub/adus/p/1... AI will change white collar work: but no one is discussing actually useful examples. Some practical uses for AI all for < 50$/month. Tailored to biotech

open.substack.com

AI for Research: A Practical Guide for Analysts

The pragmatists guide to using AI for analysis, tailored for biotech. All for < 40$/month

000

Reposted by Adu Subramanian

Frank S. David @franksdavid.bsky.social · 21/12/2024

Detailed FDA analysis by @plainyogurt21.bsky.social with many case studies — recommended! (Bookmarking for my drug dev course this spring.) adus.substack.com/p/fda-and-re...

adus.substack.com

FDA and regulatory flexibility

An exploration into FDA flexibility for rare diseases, setting the stage for the next 4 years

173

Adu Subramanian @plainyogurt21.bsky.social · 23/11/2024

This is what ChatGPT says is the impact and thoughts on marty makary ( I asked to source based on pre September 2024 to avoid recent articles). All of it is a bit vague but makes sense. Overall, His focus is likely on large companies and transparency.

100

Adu Subramanian @plainyogurt21.bsky.social · 23/11/2024

$BBIO, Everyone on their toes for the last few hours, Label looks clean with mortality benefit. Now up to execution. Expecting > 30% first line share. Patent issues will weigh on it. Important to note the royalties received on FDA approval to alleviate the cash situation

030

Adu Subramanian @plainyogurt21.bsky.social · 21/11/2024

Really good list from @franksdavid.bsky.social . I think refreshing the basics and looking back on history through some of the books he mentioned is helpful for everyone. Pairs well with my list of biotech investors resources compiled here: x.com/plainyogurt2...

x.com

031

Adu Subramanian @plainyogurt21.bsky.social · 21/11/2024

blue sky feels more like the early internet. There might be something here but until it hits a critical mass, I’m gonna see random posts in my feed. The amount of content is simple not enough to maintain a large feed imo….yet

000

Adu Subramanian @plainyogurt21.bsky.social · 20/11/2024

I recently did a post with my takeaways from #AHA24 with relevant updates on ATTR-Cardiomyopathy (TTR silencing, editing, and Acoramidis, Danon Disease with Rocket Pharmaceuticals and an under the radar abstract from Tectonic therapeutics. adus.substack.com/p/quick-take...

adus.substack.com

Quick take: AHA 2024 - ATTR, Danon, Relaxin

NTLA, ALNY, BBIO, RCKT, TECX

131